Results 141 to 150 of about 414,063 (320)

Thermalized and mixed meanfield ADP potentials for magnesium hydrides [PDF]

open access: yesarXiv
We develop meanfield approximation and numerical quadrature schemes for the evaluation of Angular-Dependent interatomic Potentials (ADPs) for magnesium and magnesium hydrides at finite temperature (thermalization) and arbitrary atomic molar fractions (mixing) within a non-equilibrium statistical mechanical framework and derive local equilibrium ...
arxiv  

Microstructure-corrosion behaviour relationship of micro-alloyed Mg-0.5Zn alloy with the addition of Ca, Sr, Ag, In and Cu

open access: yesMaterials & Design, 2020
The effects of micro-addition (0.2 wt.%) of Ca, Sr, Ag, In and Cu on the microstructure and corrosion properties of the as-cast Mg-0.5Zn alloy were systematically studied.
Yiming Jin   +13 more
doaj  

Substitution of Ni for Zn on microstructure and mechanical properties of Mg–Gd–Y–Zn–Mn alloy

open access: yesJournal of Magnesium and Alloys, 2017
This study analyzes the effect of substitution of Ni for Zn on microstructure and mechanical properties of Mg–Gd–Y–Zn–Mn alloy. Our results show that the volume fraction of Mg5(Gd, Y) and (Mg, Zn)3RE phase decreased and LPSO phase increased with more ...
Rongqing Zhang   +4 more
doaj  

Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share clinical, pathological, and genetic risk factors, including GBA1 and APOEε4 mutations. Biomarkers associated with the pathways of these mutations, such as glucocerebrosidase enzyme (GCase) activity and amyloid‐beta 42 (Aβ42) levels, may hold potential as predictive ...
Maria Camila Gonzalez   +15 more
wiley   +1 more source

Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy